These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8360187)

  • 21. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
    Berrevoets CA; Veldscholte J; Mulder E
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen and glucocorticoid regulation of androgen receptor cDNA expression.
    Burnstein KL; Maiorino CA; Dai JL; Cameron DJ
    Mol Cell Endocrinol; 1995 Dec; 115(2):177-86. PubMed ID: 8824893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences.
    Zhou ZX; Sar M; Simental JA; Lane MV; Wilson EM
    J Biol Chem; 1994 May; 269(18):13115-23. PubMed ID: 8175737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide.
    Wong C; Kelce WR; Sar M; Wilson EM
    J Biol Chem; 1995 Aug; 270(34):19998-20003. PubMed ID: 7650017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function.
    Buchanan G; Yang M; Harris JM; Nahm HS; Han G; Moore N; Bentel JM; Matusik RJ; Horsfall DJ; Marshall VR; Greenberg NM; Tilley WD
    Mol Endocrinol; 2001 Jan; 15(1):46-56. PubMed ID: 11145738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamic acid 709 substitutions highlight the importance of the interaction between androgen receptor helices H3 and H12 for androgen and antiandrogen actions.
    Georget V; Bourguet W; Lumbroso S; Makni S; Sultan C; Nicolas JC
    Mol Endocrinol; 2006 Apr; 20(4):724-34. PubMed ID: 16373394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.
    Zhou ZX; Lane MV; Kemppainen JA; French FS; Wilson EM
    Mol Endocrinol; 1995 Feb; 9(2):208-18. PubMed ID: 7776971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors.
    Kupfer SR; Marschke KB; Wilson EM; French FS
    J Biol Chem; 1993 Aug; 268(23):17519-27. PubMed ID: 8349631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization.
    Jenster G; van der Korput HA; van Vroonhoven C; van der Kwast TH; Trapman J; Brinkmann AO
    Mol Endocrinol; 1991 Oct; 5(10):1396-404. PubMed ID: 1775129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei.
    Karvonen U; Jänne OA; Palvimo JJ
    FEBS Lett; 2002 Jul; 523(1-3):43-7. PubMed ID: 12123801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
    Berrevoets CA; Umar A; Trapman J; Brinkmann AO
    Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system.
    Christensen K; Estes PA; Oñate SA; Beck CA; DeMarzo A; Altmann M; Lieberman BA; St John J; Nordeen SK; Edwards DP
    Mol Endocrinol; 1991 Nov; 5(11):1755-70. PubMed ID: 1779977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
    Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
    Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis of androgen receptor binding to selective androgen response elements.
    Shaffer PL; Jivan A; Dollins DE; Claessens F; Gewirth DT
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4758-63. PubMed ID: 15037741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
    Govindan MV
    Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.
    Warriar N; Pagé N; Koutsilieris M; Govindan MV
    Prostate; 1994 Apr; 24(4):176-86. PubMed ID: 8146066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of a partial human androgen receptor in E. coli: characterization of steroid binding, DNA binding, and immunological properties.
    Young CY; Qiu SD; Prescott JL; Tindall DJ
    Mol Endocrinol; 1990 Dec; 4(12):1841-9. PubMed ID: 2127955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation.
    Rundlett SE; Miesfeld RL
    Mol Cell Endocrinol; 1995 Mar; 109(1):1-10. PubMed ID: 7789609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
    Zhou ZX; He B; Hall SH; Wilson EM; French FS
    Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
    Nguyen TV; Yao M; Pike CJ
    Endocrinology; 2007 Jun; 148(6):2936-43. PubMed ID: 17347309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.